Histone methyltransferase EZH2 is transcriptionally induced by estradiol as well as estrogenic endocrine disruptors bisphenol-a and diethylstilbestrol

Journal of Molecular Biology

Volumn 426, Issue 20, 2014, Pages 3426-3441

  Bhan, Arunoday ^a   Hussain, Imran ^a   Ansari, Khairul I ^a   Bobzean, Samara A M ^a   Perrotti, Linda I ^a   Mandal, Subhrangsu S ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE PCAF; MIXED LINEAGE LEUKEMIA PROTEIN; RNA; TRANSCRIPTION FACTOR EZH2; BENZHYDRYL DERIVATIVE; DNA BINDING PROTEIN; ENDOCRINE DISRUPTOR; ESTROGEN; EZH2 PROTEIN, HUMAN; EZH2 PROTEIN, RAT; MLL2 PROTEIN, HUMAN; MLL3 PROTEIN, HUMAN; PHENOL DERIVATIVE; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; TUMOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; RAT; RNA EXTRACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; MCF 7 CELL LINE; METABOLISM; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; UDDER; WESTERN BLOTTING;

ANIMALS; BENZHYDRYL COMPOUNDS; BLOTTING, WESTERN; CELL LINE, TUMOR; DIETHYLSTILBESTROL; DNA-BINDING PROTEINS; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGENS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAMMARY GLANDS, ANIMAL; MCF-7 CELLS; NEOPLASM PROTEINS; OVARIECTOMY; PHENOLS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84907571632     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2014.07.025     Document Type: Article

References (100)

1. P. Guglielmelli, F. Biamonte, J. Score, C. Hidalgo-Curtis, F. Cervantes, and M. Maffioli EZH2 mutational status predicts poor survival in myelofibrosis Blood 118 2011 5227 5234
2. K. Holm, D. Grabau, K. Lövgren, S. Aradottir, S. Gruvberger-Saal, and J. Howlin Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes Mol Oncol 6 2012 494 506
3. T.K. Kerppola Polycomb group complexes - many combinations, many functions Trends Cell Biol 19 2009 692 704
4. A. Sparmann, and Maarten van Lohuizen Polycomb silencers control cell fate, development and cancer Nat Rev Cancer 6 2006 846 856
5. R. Margueron, and Danny Reinberg The Polycomb complex PRC2 and its mark in life Nature 469 2011 343 349
6. D. Pasini, Adrian P. Bracken, Michael R. Jensen, Eros Lazzerini Denchi, and Kristian Helin Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity EMBO J 23 2004 4061 4071
7. R. Cao, L. Wang, H. Wang, L. Xia, H. Erdjument-Bromage, and P. Tempst Role of histone H3 lysine 27 methylation in Polycomb-group silencing Science 298 2002 1039 1043
8. R. Margueron, Neil Justin, Katsuhito Ohno, Miriam L. Sharpe, Jinsook Son, and I.I.I. Drury Role of the polycomb protein EED in the propagation of repressive histone marks Nature 461 2009 762 767
9. C. Xu, C. Bian, W. Yang, M. Galka, H. Ouyang, and C. Chen Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2) Proc Natl Acad Sci 107 2010 19266 19271
10. R. Bonasio, S.J. Tu, and D. Reinberg Molecular signals of epigenetic states Science 330 2010 612 616
11. L. Ringrose, and R. Paro Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins Annu Rev Genet 38 2004 413 443
12. M. Ku, R. Koche, E. Rheinbay, E. Mendenhall, M. Endoh, and T. Mikkelsen Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains PLoS Genet 4 2008 e1000242
13. R. Margueron, G.H. Li, K. Sarma, A. Blais, J. Zavadil, and C.L. Woodcock Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms Mol Cell 32 2008 503 518
14. A. Bhan, I. Hussain, K.I. Ansari, S. Kasiri, A. Bashyal, and S.S. Mandal Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol J Mol Biol 425 2013 3707 3722
15. A. Bhan, I. Hussain, K.I. Ansari, S.A. Bobzean, L.I. Perrotti, and S.S. Mandal Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo J Steroid Biochem Mol Biol 141 2014 160 170
16. J. Das, A. Bhan, S.S. Mandal, and C.J. Lovely Total syntheses and cytotoxicity of kealiiquinone, 2-deoxy-2-aminokealiiquinone and analogs Bioorg Med Chem Lett 23 2013 6183 6187
17. S. Kasiri, K.I. Ansari, I. Hussain, A. Bhan, and S.S. Mandal Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and induces apoptosis in tumor cells and over expression of HOXC13 induces 3D-colony formation RSC Adv 3 2013 3260 3269
18. S. Weikert, F. Christoph, J. Köllermann, M. Müller, M. Schrader, and K. Miller Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas Int J Mol Med 16 2005 349 352
19. T. Sudo, T. Utsunomiya, K. Mimori, H. Nagahara, K. Ogawa, and H. Inoue Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma Br J Cancer 92 2005 1754 1758
20. P.W. Lewis, M.M. Muller, M.S. Koletsky, F. Cordero, S. Lin, and L.A. Banaszynski Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma Science 340 2013 857 861
21. T. Ernst, A.J. Chase, J. Score, C.E. Hidalgo-Curtis, C. Bryant, and A.V. Jones Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nat Genet 42 2010 722 726
22. G. Nikoloski, S.M.C. Langemeijer, R.P. Kuiper, R. Knops, M. Massop, and E.R.L.T.M. Tonnissen Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes Nat Genet 42 2010 665 667
23. A.H. Shih, O. Abdel-Wahab, J.P. Patel, and R.L. Levine The role of mutations in epigenetic regulators in myeloid malignancies Nat Rev Cancer 12 2012 599 612
24. S. Varambally, and D. S., Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, & Pienta KJ, S. R., Otte AP, Rubin MA, Chinnaiyan AM. Nature. 2002, 419:624-629. The polycomb group protein EZH2 is involved in progression of prostate cancer Nature 419 2002 624 629
25. P.A. Croonquist, Van Ness, and Brian The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype Oncogene 24 2005 6269 6280
26. C.G. Kleer, Q. Cao, S. Varambally, R. Shen, I. Ota, and S.A. Tomlins EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc Natl Acad Sci 100 2003 11606 11611
27. I.M. Bachmann, O.J. Halvorsen, K. Collett, I.M. Stefansson, O. Straume, and S.A. Haukaas EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast J Clin Oncol 24 2006 268 273
28. K. Collett, G.E. Eide, J. Arnes, I.M. Stefansson, J. Eide, and A. Braaten Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer Clin Cancer Res 12 2006 1168 1174
29. T.-L. Cha, B.P. Zhou, W. Xia, Y. Wu, C.-C. Yang, and C.-T. Chen Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3 Science 310 2005 306 310
30. L. Ding, C. Erdmann, A.M. Chinnaiyan, S.D. Merajver, and C.G. Kleer Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues Cancer Res 66 2006 4095 4099
31. L. Doherty, J. Bromer, Y. Zhou, T. Aldad, and H. Taylor In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer Horm Cancer 1 2010 146 155
32. K.H. Yoo, and H. L. EZH2 methyltransferase and H3K27 methylation in breast cancer Int J Biol Sci 8 2012 59 65
33. G.H.S. Richter, S. Plehm, A. Fasan, S. Rössler, R. Unland, and I.M. Bennani-Baiti EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation Proc Natl Acad Sci 106 2009 5324 5329
34. M. Dimri, P.V. Bommi, A.A. Sahasrabuddhe, J.D. Khandekar, and G.P. Dimri Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells Carcinogenesis 31 2010 489 495
35. S. Fujii, K. Ito, Y. Ito, and A. Ochiai Enhancer of Zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation J Biol Chem 283 2008 17324 17332
36. M. Zeidler, and C.G. Kleer The Polycomb group protein enhancer of Zeste 2: its links to DNA repair and breast cancer J Mol Histol 37 2006 219 223
37. M.T. McCabe, H.M. Ott, G. Ganji, S. Korenchuk, C. Thompson, and G.S. Van Aller EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations Nature 492 2012 108 112
38. S.K. Verma, and S.D. Knight Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer Future Med Chem 5 2013 1661 1670
39. S. Nilsson, and J.A. Gustafsson Estrogen receptor action Crit Rev Eukaryot Gene Expr 12 2002 237 257
40. G.B. Tremblay, and V. Giguere Coregulators of estrogen receptor action Crit Rev Eukaryot Gene Expr 12 2002 1 22
41. S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, and G. Andersson Mechanisms of estrogen action Physiol Rev 81 2001 1535 1565
42. R. Mo, S.M. Rao, and Y.-J. Zhu Identification of the MLL2 complex as a coactivator for estrogen receptor α J Biol Chem 281 2006 15714 15720
43. K.M.A. Dreijerink, K.W. Mulder, G.S. Winkler, J.W.M. Höppener, C.J.M. Lips, and H.T.M. Timmers Menin links estrogen receptor activation to histone H3K4 trimethylation Cancer Res 66 2006 4929 4935
44. S. Lee, D.-K. Lee, Y. Dou, J. Lee, B. Lee, and E. Kwak Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases Proc Natl Acad Sci 103 2006 15392 15397
45. K.I. Ansari, B.P. Mishra, and S.S. Mandal Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression Biochim Biophys Acta (BBA)-Gene Regul Mech 1779 2008 66 73
46. M.G. Guenther, R.G. Jenner, B. Chevalier, T. Nakamura, C.M. Croce, and E. Canaani Global and Hox-specific roles for the MLL1 methyltransferase Proc Natl Acad Sci U S A 102 2005 8603 8608
47. J.L. Hess MLL: a histone methyltransferase disrupted in leukemia Trends Mol Med 10 2004 500 507
48. K.I. Ansari, S. Kasiri, and S.S. Mandal Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo Oncogene 32 2013 3359 3370
49. K.I. Ansari, S. Kasiri, B.P. Mishra, and S.S. Mandal Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo Br J Cancer 107 2012 315 324
50. B.D. Crawford, and J.L. Hess MLL core components give the green light to histone methylation ACS Chem Biol 1 2006 495 498
51. K.I. Ansari, and S.S. Mandal Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing FEBS J 277 2010 1790 1804
52. K.I. Ansari, I. Hussain, B. Shrestha, S. Kasiri, and S.S. Mandal HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment J Mol Biol 411 2011 334 349
53. K.I. Ansari, S. Kasiri, I. Hussain, S.A. Bobzean, L.I. Perrotti, and S.S. Mandal MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo Mol Endocrinol 27 2013 92 105
54. K.I. Ansari, B.P. Mishra, and S.S. Mandal MLL histone methylases in gene expression, hormone signaling and cell cycle Front Biosci 14 2009 3483 3495
55. K.I. Ansari, B. Shrestha, I. Hussain, S. Kasiri, and S.S. Mandal Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression Biochemistry 50 2011 3517 3527
56. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
57. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, and K. Umesono The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
58. S. Lee, D.H. Kim, Y.H. Goo, Y.C. Lee, S.K. Lee, and J.W. Lee Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation Mol Endocrinol 23 2009 610 619
59. D.M. Lonard, B. O'Malley, and W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation Mol Cell 27 2007 691 700
60. R. Mo, S.M. Rao, and Y.J. Zhu Identification of the MLL2 complex as a coactivator for estrogen receptor alpha J Biol Chem 281 2006 15714 15720
61. J.G. Moggs, and G. Orphanides Estrogen receptors: orchestrators of pleiotropic cellular responses EMBO Rep 2 2001 775 781
62. K.B. Horwitz, T.A. Jackson, D.L. Bain, J.K. Richer, G.S. Takimoto, and L. Tung Nuclear receptor coactivators and corepressors Mol Endocrinol 10 1996 1167 1177
63. N.J. McKenna, A.J. Cooney, F.J. DeMayo, M. Downes, C.K. Glass, and R.B. Lanz Minireview: evolution of NURSA, the nuclear receptor signaling atlas Mol Endocrinol 23 2009 740 746
64. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocr Rev 20 1999 321 344
65. O. Hermanson, C.K. Glass, and M.G. Rosenfeld Nuclear receptor coregulators: multiple modes of modification Trends Endocrinol Metab 13 2002 55 60
66. J.W. Lee, Y.C. Lee, S.Y. Na, D.J. Jung, and S.K. Lee Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors Cell Mol Life Sci 58 2001 289 297
67. C. Wang, Z. Liu, C.-W. Woo, Z. Li, L. Wang, and J.S. Wei EZH2 mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR Cancer Res 72 2012 315 324
68. J.L. Rinn, M. Kertesz, J.K. Wang, S.L. Squazzo, X. Xu, and S.A. Brugmann Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs Cell 129 2007 1311 1323
69. M.-C. Tsai, O. Manor, Y. Wan, N. Mosammaparast, J.K. Wang, and F. Lan Long noncoding RNA as modular scaffold of histone modification complexes Science 329 2010 689 693
70. A. Bhan, and S.S. Mandal Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease ChemMedChem 2014 10.1002/cmdc.201300534
71. L. Shen, J. Cui, S. Liang, Y. Pang, and P. Liu Update of research on the role of EZH2 in cancer progression Oncol Targets Ther 6 2013 321 324
72. R.M. Blair, H. Fang, W.S. Branham, B.S. Hass, S.L. Dial, and C.L. Moland The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands Toxicol Sci 54 2000 138 153
73. E.J. Yearley, E.A. Zhurova, V.V. Zhurov, and A. Alan Pinkerton Experimental electron density studies of non-steroidal synthetic estrogens: diethylstilbestrol and dienestrol J Mol Struct 890 2008 240 248
74. A.J. Bannister, E.A. Miska, D. Gorlich, and T. Kouzarides Acetylation of importin-alpha nuclear import factors by CBP/p300 Curr Biol 10 2000 467 470
75. L. Titus-Ernstoff, E.E. Hatch, R.N. Hoover, J. Palmer, E.R. Greenberg, and W. Ricker Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy Br J Cancer 84 2001 126 133
76. R. Troisi, E.E. Hatch, L. Titus-Ernstoff, M. Hyer, J.R. Palmer, and S.J. Robboy Cancer risk in women prenatally exposed to diethylstilbestrol Int J Cancer 121 2007 356 360
77. J.G. Bromer, Y. Zhou, M.B. Taylor, L. Doherty, and H.S. Taylor Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response FASEB J 24 2010 2273 2280
78. H.H. Chao, X.F. Zhang, B. Chen, B. Pan, L.J. Zhang, and L. Li Bisphenol A exposure modifies methylation of imprinted genes in mouse oocytes via the estrogen receptor signaling pathway Histochem Cell Biol 137 2012 249 259
79. V. Delfosse, M. Grimaldi, J.L. Pons, A. Boulahtouf, A. le Maire, and V. Cavailles Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes Proc Natl Acad Sci U S A 109 2012 14930 14935
80. P. Fenichel, N. Chevalier, and F. Brucker-Davis Bisphenol A: an endocrine and metabolic disruptor Ann Endocrinol (Paris) 74 2013 211 220
81. Y. Gibert, S. Sassi-Messai, J.B. Fini, L. Bernard, D. Zalko, and J.P. Cravedi Bisphenol A induces otolith malformations during vertebrate embryogenesis BMC Dev Biol 11 2011 4
82. L. Gioiosa, E. Fissore, G. Ghirardelli, S. Parmigiani, and P. Palanza Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice Horm Behav 52 2007 307 316
83. J.G. Lemmen, R.J. Arends, P.T. van der Saag, and B. van der Burg in vivo imaging of activated estrogen receptors in utero by estrogens and bisphenol A Environ Health Perspect 112 2004 1544 1549
84. C.C. Smith, and H.S. Taylor Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development FASEB J 21 2007 239 246
85. G.E. Akbas, J. Song, and H.S. Taylor A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES) J Mol Biol 340 2004 1013 1023
86. N. Ben-Jonathan, and R. Steinmetz Xenoestrogens: the emerging story of bisphenol a Trends Endocrinol Metab 9 1998 124 128
87. H. Fiege, H.-W. Voges, T. Hamamoto, S. Umemura, T. Iwata, and H. Miki Phenol derivatives Ullmann's Encyclopedia of Industrial Chemistry 2000 Wiley-VCH Verlag GmbH & Co KGaA Weinheim, Germany
88. N. Benachour, and A. Aris Toxic effects of low doses of Bisphenol-A on human placental cells Toxicol Appl Pharmacol 241 2009 322 328
89. P.T. Saunders, G. Majdic, P. Parte, M.R. Millar, J.S. Fisher, and K.J. Turner Fetal and perinatal influence of xenoestrogens on testis gene expression Adv Exp Med Biol 424 1997 99 110
90. A.V. Krishnan, P. Stathis, S.F. Permuth, L. Tokes, and D. Feldman Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving Endocrinology 132 1993 2279 2286
91. E.R. Greenberg, A.B. Barnes, L. Resseguie, J.A. Barrett, S. Burnside, and L.L. Lanza Breast cancer in mothers given diethylstilbestrol in pregnancy N Engl J Med 311 1984 1393 1398
92. E.E. Calle, C.A. Mervis, M.J. Thun, C. Rodriguez, P.A. Wingo, and C.W. Heath Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women Am J Epidemiol 144 1996 645 652
93. K.I. Ansari, I. Hussain, H.K. Das, and S.S. Mandal Overexpression of human histone methylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol FEBS J 276 2009 3299 3307
94. K.I. Ansari, I. Hussain, S. Kasiri, and S.S. Mandal HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4 J Mol Endocrinol 48 2012 61 75
95. K.I. Ansari, S. Kasiri, I. Hussain, and S.S. Mandal Mixed lineage leukemia histone methylases play critical roles in estrogen-mediated regulation of HOXC13 FEBS J 276 2009 7400 7411
96. A.M. Betancourt, I.A. Eltoum, R.A. Desmont, J. Russo, and C.A. Lamartiniere In-utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat Environ Health Perspect 118 2010 1614 1619
97. H. Maclusky, T. Hajszan, and C. Leranth The environmental estrogen bisphenol A inhibits estradiol-induced hippocampal synaptogenesis Environ Health Perspect 11 2005 675 679
98. T. Inagaki, M. Frankfurt, and V. Luine Estrogen-induced memory enhancements are blocked by acute bisphenol A in adult female rats: role of dendritic spines Endocrinology 153 2012 3357 3367
99. T. Eilam-Stock, P. Serrano, M. Frankfurt, and V. Luine Bisphenol-A impairs memory and reduces dendritic spine density in adult male rats Behav Neurosci 126 2012 175 185
100. B. Shrestha, K.I. Ansari, A. Bhan, S. Kasiri, I. Hussain, and S.S. Mandal Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue FEBS J 279 2012 3715 3726